NAD+ and Cancer: What the NMN Mouse Study Actually Found

Does boosting NAD+ promote cancer? I break down the 2019 NMN study behind the debate—what researchers tested, the pancreatic changes they observed, and why the experimental setup matters. This experiment involved NMN in genetically altered mice predisposed to pancreatic disease. It raises concerns in that specific model, but does not establish cancer risk—or prove safety—in healthy people. We cover NMN versus NAD+, inflammation, senescent-cell signaling, and the limits of applying mouse findings to humans. Read the study. #NAD #NMN #LongevityResearch